Institutional shares held 52.9 Million
35.3K calls
83K puts
Total value of holdings $124M
$82K calls
$195K puts
Market Cap $133M
56,527,200 Shares Out.
Institutional ownership 93.5%
# of Institutions 125


Latest Institutional Activity in VTYX

Top Purchases

Q3 2024
Sio Capital Management, LLC Shares Held: 1.97M ($4.63M)
Q3 2024
Ubs Group Ag Shares Held: 1.2M ($2.81M)
Q3 2024
Deerfield Management Company, L.P. (Series C) Shares Held: 6.72M ($15.8M)
Q3 2024
Bank Of America Corp Shares Held: 897K ($2.11M)
Q3 2024
Goldman Sachs Group Inc Shares Held: 1.94M ($4.55M)

Top Sells

Q3 2024
Citadel Advisors LLC Shares Held: 4.46M ($10.5M)
Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 433K ($1.02M)
Q3 2024
Morgan Stanley Shares Held: 333K ($782K)
Q3 2024
Ikarian Capital, LLC Shares Held: 193K ($453K)
Q3 2024
Graham Capital Management, L.P. Shares Held: 51K ($120K)

About VTYX

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.


Insider Transactions at VTYX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
973K Shares
From 5 Insiders
Exercise of conversion of derivative security 473K shares
Open market or private purchase 500K shares
Sell / Disposition
2.7M Shares
From 6 Insiders
Open market or private sale 22.2K shares
Other acquisition or disposition 2.67M shares

Track Institutional and Insider Activities on VTYX

Follow Ventyx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX